5 assets in Nephrolithiasis

Therapeutic assets addressing Nephrolithiasis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lidocaine Nephrolithiasis	Hans Bahlmann	P3	B (60)
Marcaine Nephrolithiasis	Hans Bahlmann	P3	B (60)
Nepenthe Nephrolithiasis	Hans Bahlmann	P3	B (60)
Bmn 255 Nephrolithiasis	BioMarin Pharmaceutical	P1	CC (43)
Ketorolac Nephrolithiasis	Hamilton Health Sciences Corporation	P3	NR ()